| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | 0.018 | 0.9 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.9 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.9 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |